APO Research
Talk to an analyst

APO RESEARCH · REPORT

Defibrinated Horse Blood

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Defibrinated Horse Blood Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

8 January 2026195 pages

Choose your research edition.

Industry ResearchDefibrinated Horse Blood Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Defibrinated Horse Blood Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Defibrinated Horse Blood Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Defibrinated Horse Blood Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Defibrinated Horse Blood Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Defibrinated Horse Blood market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Defibrinated Horse Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Defibrinated Horse Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Defibrinated Horse Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Defibrinated Horse Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Defibrinated Horse Blood include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Biowest(BioNordic A/S), Pel-Freez Biologicals, Trafalgar Scientific and HemoStat Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Defibrinated Horse Blood market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Defibrinated Horse Blood and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Defibrinated Horse Blood sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Defibrinated Horse Blood market size, projected growth trends, production technologies, key applications, and end-use industries.

Defibrinated Horse Blood Segment by Company

Thermo Fisher Scientific

TCS Biosciences

BioMérieux

E & O Laboratories Ltd

Southern Biological

Biowest(BioNordic A/S)

Pel-Freez Biologicals

Trafalgar Scientific

HemoStat Laboratories

EWC Diagnostics

Dutscher

Serana Europe

Kraeber & Co. GmbH

Bio Nutrientes Do Brasil Ltda.

Lampire Biological Laboratories, Inc.

Innovative Research Inc

Colorado Serum

SSI Diagnostica

SR Group

Szabo-Scandic

Rockland Immunochemicals, Inc.

LABone Scientific Co.Ltd.

Quad Five(Materials Bio Inc.)

Guangzhou Ruite Biotechnology Co., Ltd.

Obio Technology (Shanghai) Corp., Ltd.

Beijing Solarbio Science & Technology Co.,Ltd.

Nanjing SenBeiJia Biological Technology Co., Ltd.

Defibrinated Horse Blood Segment by Type

50ml

100ml

250ml

500ml

Others

Defibrinated Horse Blood Segment by Application

Biomedicine

Research

Defibrinated Horse Blood Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Defibrinated Horse Blood market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Defibrinated Horse Blood and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Defibrinated Horse Blood.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Defibrinated Horse Blood market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Defibrinated Horse Blood manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Defibrinated Horse Blood in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Defibrinated Horse Blood in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Defibrinated Horse Blood Industry Trends Table 2. Defibrinated Horse Blood Industry Drivers Table 3. Defibrinated Horse Blood Industry Opportunities and Challenges Table 4. Defibrinated Horse Blood Industry Restraints Table 5. Global Defibrinated Horse Blood Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Defibrinated Horse Blood Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Defibrinated Horse Blood Sales by Manufacturers (kL) & (2021-2026) Table 8. Global Defibrinated Horse Blood Sales Market Share by Manufacturers Table 9. Global Defibrinated Horse Blood Average Sales Price (USD/L) of Manufacturers (2021-2026) Table 10. Global Defibrinated Horse Blood Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Defibrinated Horse Blood Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Defibrinated Horse Blood Manufacturers, Product Type & Application Table 13. Global Defibrinated Horse Blood Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Defibrinated Horse Blood by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50ml Table 17. Major Manufacturers of 100ml Table 18. Major Manufacturers of 250ml Table 19. Major Manufacturers of 500ml Table 20. Major Manufacturers of Others Table 21. Global Defibrinated Horse Blood Sales by Type 2021 VS 2025 VS 2032 (kL) Table 22. Global Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 23. Global Defibrinated Horse Blood Sales by Type (2027-2032) & (kL) Table 24. Global Defibrinated Horse Blood Sales Market Share by Type (2021-2026) Table 25. Global Defibrinated Horse Blood Sales Market Share by Type (2027-2032) Table 26. Global Defibrinated Horse Blood Revenue by Type 2021 VS 2025 VS 2032 (kL) Table 27. Global Defibrinated Horse Blood Revenue by Type (2021-2026) & (kL) Table 28. Global Defibrinated Horse Blood Revenue by Type (2027-2032) & (kL) Table 29. Global Defibrinated Horse Blood Revenue Market Share by Type (2021-2026) Table 30. Global Defibrinated Horse Blood Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Biomedicine Table 32. Major Manufacturers of Research Table 33. Global Defibrinated Horse Blood Sales by Application 2021 VS 2025 VS 2032 (kL) Table 34. Global Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 35. Global Defibrinated Horse Blood Sales by Application (2027-2032) & (kL) Table 36. Global Defibrinated Horse Blood Sales Market Share by Application (2021-2026) Table 37. Global Defibrinated Horse Blood Sales Market Share by Application (2027-2032) Table 38. Global Defibrinated Horse Blood Revenue by Application 2021 VS 2025 VS 2032 (kL) Table 39. Global Defibrinated Horse Blood Revenue by Application (2021-2026) & (kL) Table 40. Global Defibrinated Horse Blood Revenue by Application (2027-2032) & (kL) Table 41. Global Defibrinated Horse Blood Revenue Market Share by Application (2021-2026) Table 42. Global Defibrinated Horse Blood Revenue Market Share by Application (2027-2032) Table 43. Global Defibrinated Horse Blood Sales by Region: 2021 VS 2025 VS 2032 (kL) Table 44. Global Defibrinated Horse Blood Sales by Region (2021-2026) & (kL) Table 45. Global Defibrinated Horse Blood Sales Market Share by Region (2021-2026) Table 46. Global Defibrinated Horse Blood Sales Forecasted by Region (2027-2032) & (kL) Table 47. Global Defibrinated Horse Blood Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Defibrinated Horse Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kL) Table 49. North America Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 50. North America Defibrinated Horse Blood Sales by Country (2027-2032) & (kL) Table 51. Europe Defibrinated Horse Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kL) Table 52. Europe Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 53. Europe Defibrinated Horse Blood Sales by Country (2027-2032) & (kL) Table 54. Asia Pacific Defibrinated Horse Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kL) Table 55. Asia Pacific Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 56. Asia Pacific Defibrinated Horse Blood Sales by Country (2027-2032) & (kL) Table 57. South America, Middle East and Africa Defibrinated Horse Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kL) Table 58. South America, Middle East and Africa Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 59. South America, Middle East and Africa Defibrinated Horse Blood Sales by Country (2027-2032) & (kL) Table 60. Global Defibrinated Horse Blood Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Defibrinated Horse Blood Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Defibrinated Horse Blood Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Defibrinated Horse Blood Revenue Market Share by Region (2021-2026) Table 64. Global Defibrinated Horse Blood Revenue Market Share by Region (2027-2032) Table 65. Thermo Fisher Scientific Company Information Table 66. Thermo Fisher Scientific Business Overview Table 67. Thermo Fisher Scientific Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Thermo Fisher Scientific Defibrinated Horse Blood Product Portfolio Table 69. Thermo Fisher Scientific Recent Development Table 70. TCS Biosciences Company Information Table 71. TCS Biosciences Business Overview Table 72. TCS Biosciences Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. TCS Biosciences Defibrinated Horse Blood Product Portfolio Table 74. TCS Biosciences Recent Development Table 75. BioMérieux Company Information Table 76. BioMérieux Business Overview Table 77. BioMérieux Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. BioMérieux Defibrinated Horse Blood Product Portfolio Table 79. BioMérieux Recent Development Table 80. E & O Laboratories Ltd Company Information Table 81. E & O Laboratories Ltd Business Overview Table 82. E & O Laboratories Ltd Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. E & O Laboratories Ltd Defibrinated Horse Blood Product Portfolio Table 84. E & O Laboratories Ltd Recent Development Table 85. Southern Biological Company Information Table 86. Southern Biological Business Overview Table 87. Southern Biological Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Southern Biological Defibrinated Horse Blood Product Portfolio Table 89. Southern Biological Recent Development Table 90. Biowest(BioNordic A/S) Company Information Table 91. Biowest(BioNordic A/S) Business Overview Table 92. Biowest(BioNordic A/S) Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Biowest(BioNordic A/S) Defibrinated Horse Blood Product Portfolio Table 94. Biowest(BioNordic A/S) Recent Development Table 95. Pel-Freez Biologicals Company Information Table 96. Pel-Freez Biologicals Business Overview Table 97. Pel-Freez Biologicals Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Pel-Freez Biologicals Defibrinated Horse Blood Product Portfolio Table 99. Pel-Freez Biologicals Recent Development Table 100. Trafalgar Scientific Company Information Table 101. Trafalgar Scientific Business Overview Table 102. Trafalgar Scientific Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Trafalgar Scientific Defibrinated Horse Blood Product Portfolio Table 104. Trafalgar Scientific Recent Development Table 105. HemoStat Laboratories Company Information Table 106. HemoStat Laboratories Business Overview Table 107. HemoStat Laboratories Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. HemoStat Laboratories Defibrinated Horse Blood Product Portfolio Table 109. HemoStat Laboratories Recent Development Table 110. EWC Diagnostics Company Information Table 111. EWC Diagnostics Business Overview Table 112. EWC Diagnostics Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. EWC Diagnostics Defibrinated Horse Blood Product Portfolio Table 114. EWC Diagnostics Recent Development Table 115. Dutscher Company Information Table 116. Dutscher Business Overview Table 117. Dutscher Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Dutscher Defibrinated Horse Blood Product Portfolio Table 119. Dutscher Recent Development Table 120. Serana Europe Company Information Table 121. Serana Europe Business Overview Table 122. Serana Europe Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Serana Europe Defibrinated Horse Blood Product Portfolio Table 124. Serana Europe Recent Development Table 125. Kraeber & Co. GmbH Company Information Table 126. Kraeber & Co. GmbH Business Overview Table 127. Kraeber & Co. GmbH Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Kraeber & Co. GmbH Defibrinated Horse Blood Product Portfolio Table 129. Kraeber & Co. GmbH Recent Development Table 130. Bio Nutrientes Do Brasil Ltda. Company Information Table 131. Bio Nutrientes Do Brasil Ltda. Business Overview Table 132. Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Product Portfolio Table 134. Bio Nutrientes Do Brasil Ltda. Recent Development Table 135. Lampire Biological Laboratories, Inc. Company Information Table 136. Lampire Biological Laboratories, Inc. Business Overview Table 137. Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Product Portfolio Table 139. Lampire Biological Laboratories, Inc. Recent Development Table 140. Innovative Research Inc Company Information Table 141. Innovative Research Inc Business Overview Table 142. Innovative Research Inc Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Innovative Research Inc Defibrinated Horse Blood Product Portfolio Table 144. Innovative Research Inc Recent Development Table 145. Colorado Serum Company Information Table 146. Colorado Serum Business Overview Table 147. Colorado Serum Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Colorado Serum Defibrinated Horse Blood Product Portfolio Table 149. Colorado Serum Recent Development Table 150. SSI Diagnostica Company Information Table 151. SSI Diagnostica Business Overview Table 152. SSI Diagnostica Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. SSI Diagnostica Defibrinated Horse Blood Product Portfolio Table 154. SSI Diagnostica Recent Development Table 155. SR Group Company Information Table 156. SR Group Business Overview Table 157. SR Group Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. SR Group Defibrinated Horse Blood Product Portfolio Table 159. SR Group Recent Development Table 160. Szabo-Scandic Company Information Table 161. Szabo-Scandic Business Overview Table 162. Szabo-Scandic Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Szabo-Scandic Defibrinated Horse Blood Product Portfolio Table 164. Szabo-Scandic Recent Development Table 165. Rockland Immunochemicals, Inc. Company Information Table 166. Rockland Immunochemicals, Inc. Business Overview Table 167. Rockland Immunochemicals, Inc. Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Rockland Immunochemicals, Inc. Defibrinated Horse Blood Product Portfolio Table 169. Rockland Immunochemicals, Inc. Recent Development Table 170. LABone Scientific Co.Ltd. Company Information Table 171. LABone Scientific Co.Ltd. Business Overview Table 172. LABone Scientific Co.Ltd. Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. LABone Scientific Co.Ltd. Defibrinated Horse Blood Product Portfolio Table 174. LABone Scientific Co.Ltd. Recent Development Table 175. Quad Five(Materials Bio Inc.) Company Information Table 176. Quad Five(Materials Bio Inc.) Business Overview Table 177. Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 178. Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Product Portfolio Table 179. Quad Five(Materials Bio Inc.) Recent Development Table 180. Guangzhou Ruite Biotechnology Co., Ltd. Company Information Table 181. Guangzhou Ruite Biotechnology Co., Ltd. Business Overview Table 182. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 183. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Product Portfolio Table 184. Guangzhou Ruite Biotechnology Co., Ltd. Recent Development Table 185. Obio Technology (Shanghai) Corp., Ltd. Company Information Table 186. Obio Technology (Shanghai) Corp., Ltd. Business Overview Table 187. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 188. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Product Portfolio Table 189. Obio Technology (Shanghai) Corp., Ltd. Recent Development Table 190. Beijing Solarbio Science & Technology Co.,Ltd. Company Information Table 191. Beijing Solarbio Science & Technology Co.,Ltd. Business Overview Table 192. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 193. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Product Portfolio Table 194. Beijing Solarbio Science & Technology Co.,Ltd. Recent Development Table 195. Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information Table 196. Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview Table 197. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 198. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Product Portfolio Table 199. Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Development Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Defibrinated Horse Blood Distributors List Table 203. Defibrinated Horse Blood Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Defibrinated Horse Blood Product Image Figure 2. Global Defibrinated Horse Blood Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Defibrinated Horse Blood Market Size (2021-2032) & (US$ Million) Figure 4. Global Defibrinated Horse Blood Sales (2021-2032) & (kL) Figure 5. Global Defibrinated Horse Blood Average Price (USD/L) & (2021-2032) Figure 6. Global Top 5 and 10 Defibrinated Horse Blood Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50ml Image Figure 9. 100ml Image Figure 10. 250ml Image Figure 11. 500ml Image Figure 12. Others Image Figure 13. Global Defibrinated Horse Blood Sales by Type (2021 VS 2025 VS 2032) & (kL) Figure 14. Global Defibrinated Horse Blood Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Defibrinated Horse Blood Sales Market Share by Type (2021-2032) Figure 16. Global Defibrinated Horse Blood Revenue by Type (2021 VS 2025 VS 2032) & (kL) Figure 17. Global Defibrinated Horse Blood Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Defibrinated Horse Blood Revenue Market Share by Type (2021-2032) Figure 19. Biomedicine Image Figure 20. Research Image Figure 21. Global Defibrinated Horse Blood Sales by Application (2021 VS 2025 VS 2032) & (kL) Figure 22. Global Defibrinated Horse Blood Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Defibrinated Horse Blood Sales Market Share by Application (2021-2032) Figure 24. Global Defibrinated Horse Blood Revenue by Application (2021 VS 2025 VS 2032) & (kL) Figure 25. Global Defibrinated Horse Blood Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Defibrinated Horse Blood Revenue Market Share by Application (2021-2032) Figure 27. North America Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 28. North America Defibrinated Horse Blood Sales Market Share by Country (2021-2032) Figure 29. U.S. Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 30. Canada Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 31. Mexico Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 32. Europe Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 33. Europe Defibrinated Horse Blood Sales Market Share by Country (2021-2032) Figure 34. Germany Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 35. France Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 36. U.K. Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 37. Italy Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 38. Netherlands Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 39. Asia Pacific Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 40. Asia Pacific Defibrinated Horse Blood Sales Market Share by Country (2021-2032) Figure 41. China Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 42. Japan Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 43. South Korea Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 44. Southeast Asia Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 45. India Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 46. Australia Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 47. South America, Middle East and Africa Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 48. South America, Middle East and Africa Defibrinated Horse Blood Sales Market Share by Country (2021-2032) Figure 49. Brazil Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 50. South Africa Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 51. Saudi Arabia Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 52. Turkey Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 53. Argentina Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 54. UAE Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 55. Egypt Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 56. Chile Defibrinated Horse Blood Sales and Growth Rate (2021-2032) & (kL) Figure 57. Global Defibrinated Horse Blood Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Defibrinated Horse Blood Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Figure 60. North America Defibrinated Horse Blood Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Figure 62. Europe Defibrinated Horse Blood Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Defibrinated Horse Blood Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Defibrinated Horse Blood Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Defibrinated Horse Blood Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Defibrinated Horse Blood Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml
  • 100ml
  • 250ml
  • 500ml
  • Others
Applications
  • Biomedicine
  • Research
Companies covered
  • Thermo Fisher Scientific
  • TCS Biosciences
  • BioMérieux
  • E & O Laboratories Ltd
  • Southern Biological
  • Biowest(BioNordic A/S)
  • Pel-Freez Biologicals
  • Trafalgar Scientific
  • HemoStat Laboratories
  • EWC Diagnostics
  • Dutscher
  • Serana Europe
  • Kraeber & Co. GmbH
  • Bio Nutrientes Do Brasil Ltda.
  • Lampire Biological Laboratories, Inc.
  • Innovative Research Inc
  • Colorado Serum
  • SSI Diagnostica
  • SR Group
  • Szabo-Scandic
  • Rockland Immunochemicals, Inc.
  • LABone Scientific Co.Ltd.
  • Quad Five(Materials Bio Inc.)
  • Guangzhou Ruite Biotechnology Co., Ltd.
  • Obio Technology (Shanghai) Corp., Ltd.
  • Beijing Solarbio Science & Technology Co.,Ltd.
  • Nanjing SenBeiJia Biological Technology Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Defibrinated Horse Blood Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Defibrinated Horse Blood Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Defibrinated Horse Blood Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Defibrinated Horse Blood Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Defibrinated Horse Blood Market Dynamics
  1. 2.1 Defibrinated Horse Blood Industry Trends
  2. 2.2 Defibrinated Horse Blood Industry Drivers
  3. 2.3 Defibrinated Horse Blood Industry Opportunities and Challenges
  4. 2.4 Defibrinated Horse Blood Industry Restraints
3 Defibrinated Horse Blood Market by Manufacturers
  1. 3.1 Global Defibrinated Horse Blood Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Defibrinated Horse Blood Sales by Manufacturers (2021-2026)
  3. 3.3 Global Defibrinated Horse Blood Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Defibrinated Horse Blood Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Defibrinated Horse Blood Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Defibrinated Horse Blood Manufacturers, Product Type & Application
  7. 3.7 Global Defibrinated Horse Blood Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Defibrinated Horse Blood Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Defibrinated Horse Blood Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Defibrinated Horse Blood Tier 1, Tier 2, and Tier 3
4 Defibrinated Horse Blood Market by Type
  1. 4.1 Defibrinated Horse Blood Type Introduction
  2. 4.1.1 50ml
  3. 4.1.2 100ml
  4. 4.1.3 250ml
  5. 4.1.4 500ml
  6. 4.1.5 Others
  7. 4.2 Global Defibrinated Horse Blood Sales by Type
  8. 4.2.1 Global Defibrinated Horse Blood Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Defibrinated Horse Blood Sales by Type (2021-2032)
  10. 4.2.3 Global Defibrinated Horse Blood Sales Market Share by Type (2021-2032)
  11. 4.3 Global Defibrinated Horse Blood Revenue by Type
  12. 4.3.1 Global Defibrinated Horse Blood Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Defibrinated Horse Blood Revenue by Type (2021-2032)
  14. 4.3.3 Global Defibrinated Horse Blood Revenue Market Share by Type (2021-2032)
5 Defibrinated Horse Blood Market by Application
  1. 5.1 Defibrinated Horse Blood Application Introduction
  2. 5.1.1 Biomedicine
  3. 5.1.2 Research
  4. 5.2 Global Defibrinated Horse Blood Sales by Application
  5. 5.2.1 Global Defibrinated Horse Blood Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Defibrinated Horse Blood Sales by Application (2021-2032)
  7. 5.2.3 Global Defibrinated Horse Blood Sales Market Share by Application (2021-2032)
  8. 5.3 Global Defibrinated Horse Blood Revenue by Application
  9. 5.3.1 Global Defibrinated Horse Blood Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Defibrinated Horse Blood Revenue by Application (2021-2032)
  11. 5.3.3 Global Defibrinated Horse Blood Revenue Market Share by Application (2021-2032)
6 Global Defibrinated Horse Blood Sales by Region
  1. 6.1 Global Defibrinated Horse Blood Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Defibrinated Horse Blood Sales by Region (2021-2032)
  3. 6.2.1 Global Defibrinated Horse Blood Sales by Region (2021-2026)
  4. 6.2.2 Global Defibrinated Horse Blood Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Defibrinated Horse Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Defibrinated Horse Blood Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Defibrinated Horse Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Defibrinated Horse Blood Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Defibrinated Horse Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Defibrinated Horse Blood Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Defibrinated Horse Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Defibrinated Horse Blood Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Defibrinated Horse Blood Revenue by Region
  1. 7.1 Global Defibrinated Horse Blood Revenue by Region
  2. 7.1.1 Global Defibrinated Horse Blood Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Defibrinated Horse Blood Revenue by Region (2021-2026)
  4. 7.1.3 Global Defibrinated Horse Blood Revenue by Region (2027-2032)
  5. 7.1.4 Global Defibrinated Horse Blood Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Defibrinated Horse Blood Revenue (2021-2032)
  8. 7.2.2 North America Defibrinated Horse Blood Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Defibrinated Horse Blood Revenue (2021-2032)
  11. 7.3.2 Europe Defibrinated Horse Blood Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Defibrinated Horse Blood Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Defibrinated Horse Blood Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Defibrinated Horse Blood Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Defibrinated Horse Blood Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Defibrinated Horse Blood Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 TCS Biosciences
  8. 8.2.1 TCS Biosciences Company Information
  9. 8.2.2 TCS Biosciences Business Overview
  10. 8.2.3 TCS Biosciences Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 TCS Biosciences Defibrinated Horse Blood Product Portfolio
  12. 8.2.5 TCS Biosciences Recent Developments
  13. 8.3 BioMérieux
  14. 8.3.1 BioMérieux Company Information
  15. 8.3.2 BioMérieux Business Overview
  16. 8.3.3 BioMérieux Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioMérieux Defibrinated Horse Blood Product Portfolio
  18. 8.3.5 BioMérieux Recent Developments
  19. 8.4 E & O Laboratories Ltd
  20. 8.4.1 E & O Laboratories Ltd Company Information
  21. 8.4.2 E & O Laboratories Ltd Business Overview
  22. 8.4.3 E & O Laboratories Ltd Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 E & O Laboratories Ltd Defibrinated Horse Blood Product Portfolio
  24. 8.4.5 E & O Laboratories Ltd Recent Developments
  25. 8.5 Southern Biological
  26. 8.5.1 Southern Biological Company Information
  27. 8.5.2 Southern Biological Business Overview
  28. 8.5.3 Southern Biological Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Southern Biological Defibrinated Horse Blood Product Portfolio
  30. 8.5.5 Southern Biological Recent Developments
  31. 8.6 Biowest(BioNordic A/S)
  32. 8.6.1 Biowest(BioNordic A/S) Company Information
  33. 8.6.2 Biowest(BioNordic A/S) Business Overview
  34. 8.6.3 Biowest(BioNordic A/S) Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biowest(BioNordic A/S) Defibrinated Horse Blood Product Portfolio
  36. 8.6.5 Biowest(BioNordic A/S) Recent Developments
  37. 8.7 Pel-Freez Biologicals
  38. 8.7.1 Pel-Freez Biologicals Company Information
  39. 8.7.2 Pel-Freez Biologicals Business Overview
  40. 8.7.3 Pel-Freez Biologicals Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pel-Freez Biologicals Defibrinated Horse Blood Product Portfolio
  42. 8.7.5 Pel-Freez Biologicals Recent Developments
  43. 8.8 Trafalgar Scientific
  44. 8.8.1 Trafalgar Scientific Company Information
  45. 8.8.2 Trafalgar Scientific Business Overview
  46. 8.8.3 Trafalgar Scientific Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Trafalgar Scientific Defibrinated Horse Blood Product Portfolio
  48. 8.8.5 Trafalgar Scientific Recent Developments
  49. 8.9 HemoStat Laboratories
  50. 8.9.1 HemoStat Laboratories Company Information
  51. 8.9.2 HemoStat Laboratories Business Overview
  52. 8.9.3 HemoStat Laboratories Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HemoStat Laboratories Defibrinated Horse Blood Product Portfolio
  54. 8.9.5 HemoStat Laboratories Recent Developments
  55. 8.10 EWC Diagnostics
  56. 8.10.1 EWC Diagnostics Company Information
  57. 8.10.2 EWC Diagnostics Business Overview
  58. 8.10.3 EWC Diagnostics Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 EWC Diagnostics Defibrinated Horse Blood Product Portfolio
  60. 8.10.5 EWC Diagnostics Recent Developments
  61. 8.11 Dutscher
  62. 8.11.1 Dutscher Company Information
  63. 8.11.2 Dutscher Business Overview
  64. 8.11.3 Dutscher Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dutscher Defibrinated Horse Blood Product Portfolio
  66. 8.11.5 Dutscher Recent Developments
  67. 8.12 Serana Europe
  68. 8.12.1 Serana Europe Company Information
  69. 8.12.2 Serana Europe Business Overview
  70. 8.12.3 Serana Europe Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Serana Europe Defibrinated Horse Blood Product Portfolio
  72. 8.12.5 Serana Europe Recent Developments
  73. 8.13 Kraeber & Co. GmbH
  74. 8.13.1 Kraeber & Co. GmbH Company Information
  75. 8.13.2 Kraeber & Co. GmbH Business Overview
  76. 8.13.3 Kraeber & Co. GmbH Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Kraeber & Co. GmbH Defibrinated Horse Blood Product Portfolio
  78. 8.13.5 Kraeber & Co. GmbH Recent Developments
  79. 8.14 Bio Nutrientes Do Brasil Ltda.
  80. 8.14.1 Bio Nutrientes Do Brasil Ltda. Company Information
  81. 8.14.2 Bio Nutrientes Do Brasil Ltda. Business Overview
  82. 8.14.3 Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Product Portfolio
  84. 8.14.5 Bio Nutrientes Do Brasil Ltda. Recent Developments
  85. 8.15 Lampire Biological Laboratories, Inc.
  86. 8.15.1 Lampire Biological Laboratories, Inc. Company Information
  87. 8.15.2 Lampire Biological Laboratories, Inc. Business Overview
  88. 8.15.3 Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Product Portfolio
  90. 8.15.5 Lampire Biological Laboratories, Inc. Recent Developments
  91. 8.16 Innovative Research Inc
  92. 8.16.1 Innovative Research Inc Company Information
  93. 8.16.2 Innovative Research Inc Business Overview
  94. 8.16.3 Innovative Research Inc Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Innovative Research Inc Defibrinated Horse Blood Product Portfolio
  96. 8.16.5 Innovative Research Inc Recent Developments
  97. 8.17 Colorado Serum
  98. 8.17.1 Colorado Serum Company Information
  99. 8.17.2 Colorado Serum Business Overview
  100. 8.17.3 Colorado Serum Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Colorado Serum Defibrinated Horse Blood Product Portfolio
  102. 8.17.5 Colorado Serum Recent Developments
  103. 8.18 SSI Diagnostica
  104. 8.18.1 SSI Diagnostica Company Information
  105. 8.18.2 SSI Diagnostica Business Overview
  106. 8.18.3 SSI Diagnostica Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 SSI Diagnostica Defibrinated Horse Blood Product Portfolio
  108. 8.18.5 SSI Diagnostica Recent Developments
  109. 8.19 SR Group
  110. 8.19.1 SR Group Company Information
  111. 8.19.2 SR Group Business Overview
  112. 8.19.3 SR Group Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 SR Group Defibrinated Horse Blood Product Portfolio
  114. 8.19.5 SR Group Recent Developments
  115. 8.20 Szabo-Scandic
  116. 8.20.1 Szabo-Scandic Company Information
  117. 8.20.2 Szabo-Scandic Business Overview
  118. 8.20.3 Szabo-Scandic Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Szabo-Scandic Defibrinated Horse Blood Product Portfolio
  120. 8.20.5 Szabo-Scandic Recent Developments
  121. 8.21 Rockland Immunochemicals, Inc.
  122. 8.21.1 Rockland Immunochemicals, Inc. Company Information
  123. 8.21.2 Rockland Immunochemicals, Inc. Business Overview
  124. 8.21.3 Rockland Immunochemicals, Inc. Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Rockland Immunochemicals, Inc. Defibrinated Horse Blood Product Portfolio
  126. 8.21.5 Rockland Immunochemicals, Inc. Recent Developments
  127. 8.22 LABone Scientific Co.Ltd.
  128. 8.22.1 LABone Scientific Co.Ltd. Company Information
  129. 8.22.2 LABone Scientific Co.Ltd. Business Overview
  130. 8.22.3 LABone Scientific Co.Ltd. Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 LABone Scientific Co.Ltd. Defibrinated Horse Blood Product Portfolio
  132. 8.22.5 LABone Scientific Co.Ltd. Recent Developments
  133. 8.23 Quad Five(Materials Bio Inc.)
  134. 8.23.1 Quad Five(Materials Bio Inc.) Company Information
  135. 8.23.2 Quad Five(Materials Bio Inc.) Business Overview
  136. 8.23.3 Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Product Portfolio
  138. 8.23.5 Quad Five(Materials Bio Inc.) Recent Developments
  139. 8.24 Guangzhou Ruite Biotechnology Co., Ltd.
  140. 8.24.1 Guangzhou Ruite Biotechnology Co., Ltd. Company Information
  141. 8.24.2 Guangzhou Ruite Biotechnology Co., Ltd. Business Overview
  142. 8.24.3 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Product Portfolio
  144. 8.24.5 Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments
  145. 8.25 Obio Technology (Shanghai) Corp., Ltd.
  146. 8.25.1 Obio Technology (Shanghai) Corp., Ltd. Company Information
  147. 8.25.2 Obio Technology (Shanghai) Corp., Ltd. Business Overview
  148. 8.25.3 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Product Portfolio
  150. 8.25.5 Obio Technology (Shanghai) Corp., Ltd. Recent Developments
  151. 8.26 Beijing Solarbio Science & Technology Co.,Ltd.
  152. 8.26.1 Beijing Solarbio Science & Technology Co.,Ltd. Company Information
  153. 8.26.2 Beijing Solarbio Science & Technology Co.,Ltd. Business Overview
  154. 8.26.3 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Product Portfolio
  156. 8.26.5 Beijing Solarbio Science & Technology Co.,Ltd. Recent Developments
  157. 8.27 Nanjing SenBeiJia Biological Technology Co., Ltd.
  158. 8.27.1 Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information
  159. 8.27.2 Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview
  160. 8.27.3 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Product Portfolio
  162. 8.27.5 Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Defibrinated Horse Blood Value Chain Analysis
  2. 9.1.1 Defibrinated Horse Blood Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Defibrinated Horse Blood Production Mode & Process
  6. 9.2 Defibrinated Horse Blood Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Defibrinated Horse Blood Distributors
  9. 9.2.3 Defibrinated Horse Blood Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst